{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:20:22Z","timestamp":1793892022585,"version":"4.8.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jviromet.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T13:44:41Z","timestamp":1521467081000},"page":"48-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus"],"prefix":"10.1016","volume":"257","author":[{"given":"Eduardo J.M.","family":"Nascimento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew I.","family":"Bonaparte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"DiazGranados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto T.A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Huleatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Feb. (8)","key":"10.1016\/j.jviromet.2018.03.007_bib0005","article-title":"Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America","author":"Arredondo-Garc\u00eda","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0010","doi-asserted-by":"crossref","first-page":"e1760","DOI":"10.1371\/journal.pntd.0001760","article-title":"Refining the global spatial limits of dengue virus transmission by evidence-based consensus","volume":"6","author":"Brady","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0015","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2018.03.007_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0025","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0030","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.vaccine.2016.02.004","article-title":"Protective and immunological behavior of chimeric yellow fever dengue vaccine","volume":"34","author":"Halstead","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2018.03.007_bib0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.21149\/spm.v58i1.7956","article-title":"Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico\u2019s Universal Vaccination Program","volume":"58","author":"Hernandez-Avila","year":"2016","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.jviromet.2018.03.007_bib0040","series-title":"Validation of Analytical Procedures: Text and Methodology Q2 (R1)","author":"ICH Harmonized Tripartite Guideline","year":"2005"},{"key":"10.1016\/j.jviromet.2018.03.007_bib0045","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fimmu.2017.00863","article-title":"Clinical efficacy, safety, and immunogenicity of a live attenuated tetravalent dengue vaccine (CYD-TDV) in children: a systematic review with meta-analysis","volume":"8","author":"Malisheni","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0050","article-title":"Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America","author":"Moodie","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0055","series-title":"Protocols for Determination of Limits of Detection and Limits of Quantitation, Approved Guideline. NCCLS Document EP17-A","isbn-type":"print","author":"National Committee for Clinical Laboratory Standards","year":"2004","ISBN":"https:\/\/id.crossref.org\/isbn\/1562385518"},{"key":"10.1016\/j.jviromet.2018.03.007_bib0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-7439(93)80008-6","article-title":"Calibration and assay development using the four-parameter logistic model","volume":"20","author":"O\u2019Connel","year":"1993","journal-title":"Chemom. Intell. Lab Syst."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0065","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/infdis\/jiw297","article-title":"Tetravalent dengue vaccine reduces symptomatic and asymptomatic dengue virus infections in healthy children and adolescents aged 2\u201316\u202fyears in Asia and Latin America","volume":"214","author":"Olivera-Botello","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0070","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen","volume":"8","author":"Quinn","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0075","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coviro.2017.04.002","article-title":"Recent advances in human flavivirus vaccines","volume":"23","author":"Scherwitzl","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0085","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"Simmons","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0090","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","article-title":"Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development","volume":"88","author":"Timiryasova","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0095","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The human antibody response to dengue virus infection","volume":"3","author":"Wahala","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.jviromet.2018.03.007_bib0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2016.02.014","article-title":"The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design","volume":"130","author":"Watterson","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2018.03.007_bib0105","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.vaccine.2016.10.070","article-title":"Dengue vaccine: WHO position paper, July 2016 - recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093418300818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093418300818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T11:02:23Z","timestamp":1561460543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093418300818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":21,"alternative-id":["S0166093418300818"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2018.03.007","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}